Grants

Molecular Profiling of Myeloproliferative Neoplasms and Acute Myeloid Leukemia for Designing Early Diagnostic, Prognostic and Treatment Strategies (MYELOAL – EDIAPROT)

Acronym: MYELOAL – EDIAPROT

Principal investigator: Prof. Stefan N Constantinescu MD, PhD; Executive coordonator: Carmen C. Diaconu, PhD

P2X receptors as a therapeutic opportunity – PRESTO

Acronym: PRESTO

Principal investigator: for IVN Carmen C. Diaconu, PhD

The evaluation of anti-SARS-CoV-2 protection in convalescent and vaccinated subjects in the light of newly emerging variants – IMMUN_SARS_CoV

Acronym: IMMUN_SARS_CoV

Principal investigator: Lilia Matei, PhD

Wastewater-based epidemiology concept as an early warning system for SARS-CoV-2 trend and its circulating variants in a defined catchment – WARNING

Acronym: WARNING

Principal investigator: Coralia Bleotu PhD

Pan-European Response to the Impacts of COVID-19 and Future Pandemics and Epidemics – PERISCOPE

Acronym: PERISCOPE

Principal investigator: for IVN Carmen C. Diaconu, PhD

OPEN-TEST: A new strategy to improve and promote access to HIV and HCV testing in Romania

Acronym: OPEN-TEST

Principal Investigator for IVN Camelia Sultana MD, PhD

Mechanisms and biomarkers of response and resistance to current targeted therapies in gastric cancer – THERRES

Acronym: THERRES

Principal investigator: for IVN Mihaela Economescu (Chivu) PhD

ND10 bodies dynamic switch in viral chromatin remodeling during early hrHPV infection

Acronym: NOVO

Principal Investigator Anca Botezatu, PhD.

Artificial intelligence algorithms in male infertility diagnosis based on new molecular approaches

Acronym: ARIAMIND

Principal Investigator for IVN Anca Botezatu, PhD.

Evaluation of COL10A1 as a potential therapeutic target and early diagnostic biomarker in gastric cancer

Acronym: COL-DIA-THER

Principal investigator: Laura Necula PhD

Evaluation of the potential of the porous material in the treatment of microbiota

Principal investigator: Coralia Bleotu PhD

Multidisciplinary “One Health” platform of excellence for the study of neglected and emerging vector diseases

Acronym: VECTEXCEL

Principal Investigator for IVN Simona Ruta MD, PhD

Peptides derived from human lactoferrin with broad spectrum antiviral activity

Acronym: PEPTIVIR

Principal Investigator for IVN Camelia Sultana MD, PhD

Rationally designed therapeutic vaccine against HIV-1 based on a novel formulation of nanoparticle-protected mRNA

Acronym: HIV-NANOVA

Principal Investigator for IVN Simona Ruta MD, PhD

Knowledge transfer on the investigation of the anti-infective and antitumoral activity of novel cosmetic and pharmaceutical formulations based on natural extracts

Principal investigator: Coralia Bleotu PhD

Composite hydrogels based on inorganic nanoparticles and collagen with prolonged antimicrobial activity for the prevention of wound infections

Principal investigator: Coralia Bleotu PhD

The role of E6/E7 HPV16 oncogenes in chromatin remodelling through components of NURD complex (MBD2, MBD3)

Acronym: ONCONURD

Principal Investigator Anca Botezatu, PhD.

Implementation of a complex genome profiling diagnostic algorithm for patients with congenital and developmental abnormalities (CONGEN)

Acronym: CONGEN

Principal investigator: Carmen Cristina Diaconu PhD

The role of S100A4 and MAP4K4 factors in the progression of pancreatic ductal adenocarcinoma

Acronym: S100MAP

Principal Investigator for IVN Anca Botezatu, PhD

Molecular markers as predictors of post-therapeutic evolution and prognosis in differential thyroid carcinoma management

Acronym: GENITIR

Principal Investigator for IVN Anca Botezatu, PhD